The disease groups that make up the OneOncology clinical pathways program cover 90% of patients with cancer and develop best practices for treating cancer in the majority of patients, said Edward “Ted” Arrowsmith, MD, MPH, managing partner and director of research, East Tennessee Division, Tennessee Oncology.
The disease groups that make up the OneOncology clinical pathways program cover 90% of patients with cancer and develop best practices for treating cancer in the majority of patients, said Edward “Ted” Arrowsmith, MD, MPH, managing partner and director of research, East Tennessee Division, Tennessee Oncology.
Transcript
What is the role of disease groups in the OneOncology clinical pathways program?
Our idea of pathways is to have them really be bottom up and then top down. We've instituted disease groups that cover about 90% of patients with cancer. They have experts from each of the 15 practices in OneOncology, and work collaboratively to develop the pathways to develop best practices for treatment of cancer for the majority of patients. Of course, there'll be some patients who being off pathway is the right thing to do, but this is the expert consensus. It then comes up to the clinical team at OneOncology, who does clerical work and other work, and then helps push that information back to every doctor practicing across the practices in OneOncology.
How do member practices of OneOncology work with these clinical pathways day to day? How will the OneOncology annual conference help practices learn more about working with pathways?
Our pathways process is relatively new. OneOncology is a new organization, and we've been working on pathways really diligently for about 18 months. The main way that we see providers working with the pathways will be through a tool called Flatiron Assist. And the OneOncology conference this weekend is the big kind of rollout of that tool. That's a clinical decision support tool developed in conjunction with Flatiron Health who's our EMR [electronic medical record] partner. Based on the intellectual work done by the disease groups [the tool] will guide clinicians to using a pathway concordant regimen, whenever they order. That can be customized by OneOncology based on value-based care, clinical trials, or other attributes that are unique to our practices.
Enhancing Outpatient Hemophilia Care May Improve Health Outcomes and Costs
May 18th 2024Prospective data from patients attending a rural practice in West Virginia between 2016 and 2023 show that a quality improvement program that followed guideline recommendations and was tailored to specific patient needs reduced preventable bleeds and lowered costs.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen